R&D Investments Fuel Next-Gen Immunomodulator Development Amid Patent Expiry
The 'Immunomodulator Therapeutics Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
Revenue estimate for the base year 2024 is $93 billion with a CAGR of 9.0% for the study period 2024-2030.
This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting or suppressing them.
It categorizes the market by modality and key indications, providing a 6-year revenue forecast for global immunomodulator prescription drugs, alongside an analysis of key industry participants. The geographic scope encompasses North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and Latin America (LATAM), with regional revenue share estimates presented on a best-effort basis.
The report also discusses prevalent and emerging business models, analyzes trends in market access and reimbursement for immunomodulator therapies, and offers competitive assessments and revenue share analyses. It examines the factors driving and restraining growth in this space, offering insights into drug development trends, partnerships, and the investment landscape.
The report highlights key companies pioneering disruptive virtual care technologies and adjunctive therapies for effective disease management. Based on clinical needs, technological advancements, business models, and competitive dynamics, the report identifies the growth opportunities emerging from this space for market players and stakeholders to leverage. The base year is 2024, and the forecast period is from 2025 to 2030.
Growth Drivers
Rising Prevalence of Autoimmune and Inflammatory Diseases
Increasing prevalence of diseases like lupus, RA, Crohn's disease, and psoriasis is driving demand for immunomodulators like tumor necrosis factor (TNF) inhibitors (e.g., Humira, Remicade) and JAK inhibitors (e.g., Xeljanz). The rapidly aging global population is more susceptible to chronic autoimmune conditions. It is further bolstering demand for treatments tailored to older adults, such as more tolerable biologics.
Biotech Advancements
Innovations in biotech platforms and advanced modalities such as CGT, bispecific antibodies, and RNA therapies are enhancing the efficacy and safety profiles of immunomodulators and driving the development of next-gen targeted therapies. Carisma Therapeutics Inc. and Moderna, Inc. have collaborated to use Carisma's proprietary CAR-M technology and Moderna's mRNA/lipid nanoparticles (LNP) platform to develop a macrophage engineering approach for autoimmune diseases.
Growing Investment in R&D
Increased funding from both public and private sectors is accelerating R&D efforts for discovering new therapies and improving existing ones. The NIH allocates significant funding for research on immunomodulatory therapies, fostering innovation. An increasing number of M&A deals demonstrate a growing focus on immunology by big pharma.
Success in Oncology and Expanding Applications
The success of immunotherapies in oncology has raised awareness and acceptance of similar approaches in treating autoimmune and inflammatory diseases. For example, Roche's Gazyva/Gazyvaro (obinutuzumab), approved in 100 nations for several lymphoma types, is being investigated in the Phase III REGISTRY trial for lupus nephritis.
Growth Restraints
Immunomodulator Therapeutics: Growth Restraints, Global, 2025-2030
Stringent Regulatory Processes: Stringent regulatory processes for immunomodulatory treatment approval or the development of novel mechanisms of action, globally, can cause delays in market access and raise development expenses for pharmaceutical companies. Moreover, inadequate reimbursement/insurance coverage globally may deter wide-scale adoption, especially in public health systems or regions with limited healthcare resources. Inadequate coverage of high-cost new drugs would increase the expenses of managing long-term conditions, impacting patient compliance and market growth.
Potential Adverse Effects and Safety Concerns: Immunomodulators may have serious adverse effects, such as an elevated risk of infections and autoimmune responses. For example, checkpoint inhibitor use in autoimmune disease is linked to immune-related side effects that need to be carefully managed. Adverse outcomes and safety risks may lead to regulatory actions such as market recalls, limited prescriptions, and reduced patient confidence, challenging market uptake.
Patent Expiry: Expiry of blockbuster drug patents is leading to the introduction of biosimilars and generic versions, intensifying market competition, resulting in price erosions, and leading to a loss of sales revenue for branded products. For example, AbbVie's blockbuster Humira, approved for several autoimmune conditions like RA, psoriasis, Crohn's disease, and ankylosing spondylitis, started facing biosimilar competition in 2023.
Patient Inconvenience: Biotech advancements have facilitated the development of effective biologic therapies; however, therapy administration requires frequent injections or infusions, making it challenging for patients to adhere to their treatment regimens. It may affect overall patient satisfaction and treatment discontinuation.
The Impact of the Top 3 Strategic Imperatives on the Immunomodulator Therapeutics Industry
Disruptive Technologies
Why: There is an increasing incidence of autoimmune diseases, particularly impacting women. Limitations in existing therapies demand more targeted applications.
Analyst Perspective: A new wave of drug classes (JAK1, IL, calcineurin, TNF?, TYK2, PDE4), across small molecules, biologics, and cell and gene therapies, will emerge, offering enhanced efficacy and safety profiles for treating autoimmune and inflammatory conditions. There will be a growing trend towards combination therapies that utilize multiple mechanisms of action to achieve better clinical outcomes.
Internal Challenges
Why: The industry is moving toward an extended patent cliff, with several revenue-generating blockbuster drugs like Humira and Stelara losing their exclusivity, leading to revenue losses and increased biosimilar competition, creating an urgent need for pipeline growth, and driving increased research and development (R&D). Resource demands for R&D can strain budgets, especially for smaller biotech firms.
Analyst Perspective: Companies may increasingly seek strategic partnerships to share costs and risks, fostering innovation through collaborative R&D efforts. Companies that emphasize unique value propositions in these strategic alliances will be better positioned to access markets/fair pricing with drugs like JAK inhibitors and women-specific therapies. Payers will scrutinize clinical costs and patient outcomes to ensure balance and sustainable reimbursement models that reflect indication-specific needs and improve affordability.
Transformative Megatrends
Why: Healthcare systems are under pressure to contain current and future spending. Healthcare plan sponsors are considering their next moves as governments contemplate the impact of the Inflation Reduction Act (IRA) 2022, and associated price cuts in the United States.
Analyst Perspective: Firms will invest in adaptive trial designs for evidence generation to expedite approvals for novel MoA-based targeted therapies, advancing precision medicine going forward. Pharma companies will utilize diagnostic delivery services to improve patient access by partnering with telehealth/AI-enabled symptom monitoring platforms (e.g., Ada Health) and focus on an emerging market-expansion strategy. Focus on predictive convergence of drugs and digital therapeutics will likely personalize medicine and improve experiences and outcomes.
Scope of Analysis
Ecosystem in the Immunomodulator Therapeutics Sector
Growth Opportunity Universe in Immunomodulator Therapeutics Sector
Key Competitors
For more information about this report visit https://www.researchandmarkets.com/r/jxoywx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250704025568/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 07/04/2025 06:43 AM/DISC: 07/04/2025 06:43 AM
http://www.businesswire.com/news/home/20250704025568/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
A Pilates expert says these are the 8 best exercises for longevity to 'help you stay healthy in later life'
When you buy through links on our articles, Future and its syndication partners may earn a commission. If you want to live a longer, more fulfilling life – aka being able to bend down and pick something up without straining your lower back – then building a stronger, more mobile body should be a top priority. Pilates is a great way to achieve this, as it helps improve and maintain our musculoskeletal health. According to Lotty Campbell Bird, founder of The Collective Fitness Studio, this is key to helping you 'stay fit, strong, and healthy in later life.' 'Musculoskeletal health is crucial for longevity because it enables mobility, independence, and overall well-being, all of which are vital for healthy ageing,' she explains. 'Strong muscles, bones, and joints allow you to perform daily tasks, maintain an active lifestyle, and reduce the risk of falls and injuries, which can significantly impact quality of life and lifespan.' In order to help you build a stronger, resilient body, Lotty has shared eight Pilates exercises that will help enhance your musculoskeletal health. 'These exercises build core strength and postural alignment, which supports your spine and joints, prevents musculoskeletal deterioration that is common when aging, and help to maintain bone density.' Make sure you give the video above a quick watch if you're unfamiliar with the exercises (FYI, the video has been sped up, so make sure you take them slow). Focus: Spinal articulation, core engagement, glute and hamstring activation. How to: Lie on your back, knees bent, feet flat Inhale to prepare, exhale to slowly roll your spine off the mat one vertebra at a time Inhale at the top, exhale to roll back down Benefits: Improves spinal mobility, strengthens posterior chain. Reps: 8-10 Focus: Glutes, hamstrings, spinal support, pelvic stability. How to do it: From a bridge position, lift one leg off the mat into tabletop while maintaining level hips Alternate your legs Benefits: Builds leg strength and improves balance, preventing hip and lower back dysfunction. Reps: 5-6 each side Focus: Deep core muscles (transversus abdominis and pelvic floor). How to do it: Lie on your back, lift legs to tabletop or straight up, curl head and shoulders off the mat. Pulse arms vigorously up and down as you inhale for 5 counts, exhale for 5. Benefits: Activates your deep core stabilisers and helps support posture. Reps: x 10 cycles of breath Focus: Improving core control and boosting hip mobility. How to do it: Lie on your back, with your head and shoulders curled up Alternate legs as one pulls in, the other reaches long Benefits: Strengthens abdominals while improving hip mobility and coordination. Reps: 8-10 each side Focus: Back extensor muscles, shoulder stabilisers and glutes. How to do it: Lie face down, hands under your forehead and legs extended. Lift upper back off the ground, keeping your eyeline on the floor and your feet and legs still. Benefits: Supports spinal extension, counters forward postures, and improves muscular balance. Reps: 8-10 reps Focus: Hip stability, glute medius strength and pelvic alignment. How to do it: Lie on your side with one arm tucked under your head for support and stack hips on top of one another Lift top leg slowly with a flex and lower with control with a point Benefits: Strengthens hip, helps with balance and offers lower back support. Reps: 10-15 each leg Focus: Spinal flexion, hamstring stretch, postural alignment. How to do it: Sit tall with legs extended and your feet flexed Inhale to sit taller, exhale to reach forward from the spine Benefits: Lengthens spine, reduces compression, increases flexibility. Reps: 6-8 Focus: Stability of core and pelvis and hip mobility. How to do it: Lie on your back, one leg extended up, the other on the mat Circle the raised leg while keeping hips stable Benefits: Strengthens the core and improves hip joint range of motion without compromising the spine. Reps: 8-10 each side
Gizmodo
2 hours ago
- Gizmodo
Edible Microlasers Could Revolutionize Food Tracking and Safety
In a delicious turn of events, scientists succeeded in taking the optics of olive oil to create the first-ever microlaser made entirely from edible materials. If commercialized, they could offer an easy and safe way to monitor food or medications from inside your body. The technology, introduced earlier this month in the journal Advanced Optical Materials, exploits an interesting tendency for droplets of common cooking oils, which emit a photon of light when subjected to a certain amount of energy. Arrange multiple droplets in a room full of mirrors, and together they shine more brightly—like a concentrated beam of light. The researchers tested more than a dozen different types of materials—sunflower oil, cooked butter, plain water, and more—to see which would generate the cleanest laser. And the winner was olive oil. One prominent component of olive oil is chlorophyll, the molecule most commonly known to make plants green. In this case, the chlorophyll molecules, trapped in the sticky surface of olive oils, generated photons in a chain reaction of sorts, transforming the droplet of olive oil into a laser. The brightness of the chlorophyll changes in accordance with the size and density of the oil droplets, making the laser highly sensitive to environmental conditions, according to the study. For example, adding it to different dishes of food and observing changes in the laser allowed the researchers to measure things such as sugar concentration or acidity What's more, the researchers were able to encode data within the droplets akin to the lines of a barcode, into a peach compote. Surprisingly, the data—the specific date of April 26, 2017, which happens to be the first international Stop Food Waste Date—remained intact for over a year, demonstrating the microlaser's potential to safely carry information, such as the identity of a manufacturer or an expiration date. 'Since this is the first such study, there are many possibilities for developing various edible lasers and their applications, which could ultimately find their way to everyday use,' the study authors concluded.
Yahoo
3 hours ago
- Yahoo
'Menopause made me forget my name'
"I didn't believe it could just be menopause. I thought it must be a brain tumour or dementia." Kirsty Dixon's life changed overnight when she started experiencing intense brain fog at 49 years old. Kirsty, from York, was staring at her screen at work one day, when suddenly she could not remember what she was doing. "I just asked myself 'What is my name?', and I couldn't even remember my own name. "I felt like I was going mad, I thought it was only me." The problems continued when she tried to access support. "I thought, why aren't people listening to me? "I've got something really serious going on but I can't get anyone to listen." Kirsty was told by a doctor that what she had experienced was part of the menopause. It is estimated that one in three women in the UK is going through the menopause at any given time. Kirsty, learning and development adviser at the University of York, is working to raise awareness of the lesser-known symptoms and the huge impact they can have on people's lives. "Before menopause I've always been a very bubbly person, very social, bit mischievous," she said. "Menopause came along and just put a big thunder cloud over my head. "I lost myself. The number of times my husband said 'I want my Kirsty back' while he was cuddling me and I was in floods of tears." Kirsty spent the next four years "fighting it" as she could not believe that those were menopause symptoms. Then, during lockdown, Kirsty found herself researching menopause for her work. She stumbled across an article by someone who had experienced the same symptoms as her. "I got that lightbulb moment that what I was experiencing was perfectly normal, I needed to understand it and know what I could do to help myself," she said. "I went from having this constant cloud and feeling useless, to actually owning my journey." Now aged 58, Kirsty runs two support groups for women experiencing the menopause, including a nature walking group around York, and a pop-up cafe in Acomb. They are non-profit and everyone is welcome, regardless of age or gender. She hopes the groups will encourage more people to talk about the lesser-known symptoms. "When you're going through it, it can feel so lonely," she said. "You feel like it's only you, and you think you're going mad. "One of the most important things I say to people is get your support network around you, and that's family, friends, and groups like this." Sarah Mortimer, 54, has been coming to the group since it started in 2022. She experienced an uncommon symptom of self-diagnosed burning mouth syndrome during her menopause, which involves developing blisters in the mouth with a burning feeling. "It can be really isolating, so to find groups like this is amazing," she said. "It makes a huge difference, knowing there's other people going through the same rubbish that you're going through. "It's that strength in numbers thing, and there's strength in the power of talking about the menopause." The group is based in York, but people travel from as far as Leeds, Sheffield and Beverley to attend. Kirsty says that it highlights an ongoing issue around the need for more support for people going through the menopause. "No one else was running a menopause cafe in York, so it was obviously something that was missing." She is calling for more groups like this so that people do not have to travel so far to get the support they need. "What I will say now, is as a post-menopausal woman, I am the most confident, the strongest, most creative person. "If someone said to me you can have your life again, without your menopause experience, actually, I'd say no, because it's what's made me the person I am today. "If I can get through that, I can get through anything." Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North or tell us a story you think we should be covering here. 'Fire service is helping me through the menopause' 'I mistook cancer signs for the menopause' What's the point of the menopause? NHS menopause advice
